Kanabo Group Plc

("Kanabo" or the "Company")

Investor Updates

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company focussing on the development and distribution of cannabis-derived products for medical patients and wellness CBD consumers, has posted their latest investor newsletter and investor presentation to their website.

The latest Company presentation can be viewed here;

https://www.kanabogroup.com/wp-content/uploads/2022/03/Kanabo_GP_V01_230222.pdf

The Company has also posted a recent webinar with Vox Markets where Kanabo CEO, Avihu Tamir and GP Service CEO, Atul Devani discuss the GP Services acquisition. The webinar can be viewed here;

Watch the Kanabo webinar hosted by Vox Markets - Vox Markets

The latest Kanabo Investor Newsletter discussing the significant progress made over recent months can be viewed here; https://www.kanabogroup.com/press/foreword-from-the-ceo-march-11-2002/

For further information, please visit http://www.kanabogroup.com/ or contact the following:

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers. It has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.